Predicting NSCLC Survival | News Brief
July 18, 2012
A Mayo Clinic study has found that overall quality of life (QOL) measured at the time of a non-small cell lung cancer (NSCLC) diagnosis appears to significantly and independently predict survival. For patients with poor baseline QOL, the average survival was 1.6 years, compared with 5.6 years for those with strong QOL measures at diagnosis.…